Biogen Pharmachem Industries (BOM:531752) NonCurrent Deferred Liabilities: ₹0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:531752 Biogen Pharmachem Industries Ltd BOM:531752
31 GF Score
Price ₹0.28
View Full Analysis

What is Biogen Pharmachem Industries NonCurrent Deferred Liabilities?

Biogen Pharmachem Industries BOM:531752 +3.70% 31 NonCurrent Deferred Liabilities is ₹0.00 Mil as of Jun. 2026. GuruFocus rates BOM:531752 with a GF Score™ of 31/100.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Biogen Pharmachem Industries's non-current deferred liabilities for the quarter that ended in Jun. 2026 was ₹0.00 Mil.

Biogen Pharmachem Industries NonCurrent Deferred Liabilities Related Terms

Biogen Pharmachem Industries NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for Biogen Pharmachem Industries's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biogen Pharmachem Industries NonCurrent Deferred Liabilities Chart

Biogen Pharmachem Industries Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Biogen Pharmachem Industries Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:531752
31GF Score
Biogen Pharmachem Industries Ltd BOM:531752
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of ₹0.00 Mil mean?
Biogen Pharmachem Industries (BOM:531752) has a NonCurrent Deferred Liabilities of ₹0.00 Mil as of Jun. 2026. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Biogen Pharmachem Industries and its competitors.
Is Biogen Pharmachem Industries' NonCurrent Deferred Liabilities too high?
Biogen Pharmachem Industries' current NonCurrent Deferred Liabilities is ₹0.00 Mil. Overall, Biogen Pharmachem Industries has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Biogen Pharmachem Industries' NonCurrent Deferred Liabilities compare to MS and GS?
Biogen Pharmachem Industries' NonCurrent Deferred Liabilities of ₹0.00 Mil can be compared against companies in the Capital Markets industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Capital Markets company?
A good NonCurrent Deferred Liabilities depends on the Capital Markets industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Biogen Pharmachem Industries and its competitors. Biogen Pharmachem Industries's current NonCurrent Deferred Liabilities is ₹0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biogen Pharmachem Industries stock overvalued right now?
Biogen Pharmachem Industries (BOM:531752) has a current NonCurrent Deferred Liabilities of ₹0.00 Mil. The current NonCurrent Deferred Liabilities is ₹0.00 Mil. Biogen Pharmachem Industries' overall GF Score™ is 31/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For Biogen Pharmachem Industries (BOM:531752), the current NonCurrent Deferred Liabilities is ₹0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biogen Pharmachem Industries Business Description

Address Jawahar Road, Shop No. 8, First Floor, Makers-1 Building, Rajkot, GJ, IND, 360001
Biogen Pharmachem Industries Ltd is engaged in the business of trading in shares and securities in the present and future markets.
31GF Score

Get the complete analysis for BOM:531752

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹0.28
Price